U.S. federal trademark · Serial No. 98301621
Pharmaceutical preparations for the treatment of cancer in concert with radiation oncology devices or as stand-alone formulations; drug delivery agents consisting of nanoparticle compounds that facilitate delivery of pharmaceuticals for treating cancer in concert with radiation oncology devices or as stand-alone formulations
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.